Soluble VE-cadherin as a biomarker of response to immunotherapy by anti-PD1 in metastatic melanoma. Broche C, Um K, Vilgrain I, Mouret S, et al. Br J Cancer 2025 Apr 18. doi: 10.1038/s41416-025-03026.

Read + Share

Amedeo Smart

Independent Medical Education

Broche C, Um K, Vilgrain I, Mouret S, et al. Soluble VE-cadherin as a biomarker of response to immunotherapy by anti-PD1 in metastatic melanoma. Br J Cancer 2025 Apr 18. doi: 10.1038/s41416-025-03026.
PMID: 40251278